685 related articles for article (PubMed ID: 24610807)
21. Impact of cardiac resynchronization therapy on clinical outcomes in patients with continuous-flow left ventricular assist devices.
Gopinathannair R; Birks EJ; Trivedi JR; McCants KC; Sutton BS; Deam AG; Slaughter MS; Hottigoudar RU
J Card Fail; 2015 Mar; 21(3):226-32. PubMed ID: 25528199
[TBL] [Abstract][Full Text] [Related]
22. Cardiac-resynchronization therapy for mild-to-moderate heart failure.
Tang AS; Wells GA; Talajic M; Arnold MO; Sheldon R; Connolly S; Hohnloser SH; Nichol G; Birnie DH; Sapp JL; Yee R; Healey JS; Rouleau JL;
N Engl J Med; 2010 Dec; 363(25):2385-95. PubMed ID: 21073365
[TBL] [Abstract][Full Text] [Related]
23. Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.
Wilcox JE; Fonarow GC; Zhang Y; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW
Circ Heart Fail; 2014 Jan; 7(1):146-53. PubMed ID: 24178311
[TBL] [Abstract][Full Text] [Related]
24. Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data.
Zusterzeel R; Selzman KA; Sanders WE; Caños DA; O'Callaghan KM; Carpenter JL; Piña IL; Strauss DG
JAMA Intern Med; 2014 Aug; 174(8):1340-8. PubMed ID: 25090172
[TBL] [Abstract][Full Text] [Related]
25. Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker.
Schuchert A; Muto C; Maounis T; Frank R; Boulogne E; Polauck A; Padeletti L;
Europace; 2013 Jan; 15(1):71-6. PubMed ID: 22927665
[TBL] [Abstract][Full Text] [Related]
26. Mortality reduction of cardiac resynchronization and implantable cardioverter-defibrillator therapy in heart failure: an updated meta-analysis. Does recent evidence change the standard of care?
Bertoldi EG; Polanczyk CA; Cunha V; Ziegelmann PK; Beck-da-Silva L; Rohde LE
J Card Fail; 2011 Oct; 17(10):860-6. PubMed ID: 21962425
[TBL] [Abstract][Full Text] [Related]
27. Sprint Fidelis lead fractures in patients with cardiac resynchronization therapy devices: insight from the Resynchronization/Defibrillation for Ambulatory Heart Failure (RAFT) study.
Parkash R; Thibault B; Sterns L; Sapp J; Krahn A; Talajic M; Luce M; Yetisir E; Theoret-Patrick P; Wells G; Tang A
Circulation; 2012 Dec; 126(25):2928-34. PubMed ID: 23159551
[TBL] [Abstract][Full Text] [Related]
28. Dyssynchrony, contractile function, and response to cardiac resynchronization therapy.
Knappe D; Pouleur AC; Shah AM; Cheng S; Uno H; Hall WJ; Bourgoun M; Foster E; Zareba W; Goldenberg I; McNitt S; Pfeffer MA; Moss AJ; Solomon SD;
Circ Heart Fail; 2011 Jul; 4(4):433-40. PubMed ID: 21602574
[TBL] [Abstract][Full Text] [Related]
29. Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT).
Goldenberg I; Moss AJ; Hall WJ; Foster E; Goldberger JJ; Santucci P; Shinn T; Solomon S; Steinberg JS; Wilber D; Barsheshet A; McNitt S; Zareba W; Klein H;
Circulation; 2011 Oct; 124(14):1527-36. PubMed ID: 21900084
[TBL] [Abstract][Full Text] [Related]
30. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
[TBL] [Abstract][Full Text] [Related]
31. Development of a method to risk stratify patients with heart failure for 30-day readmission using implantable device diagnostics.
Whellan DJ; Sarkar S; Koehler J; Small RS; Boyle A; Warman EN; Abraham WT
Am J Cardiol; 2013 Jan; 111(1):79-84. PubMed ID: 23040596
[TBL] [Abstract][Full Text] [Related]
32. Use and Outcomes of Dual Chamber or Cardiac Resynchronization Therapy Defibrillators Among Older Patients Requiring Ventricular Pacing in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry.
Borne RT; Masoudi FA; Curtis JP; Zipse MM; Sandhu A; Hsu JC; Peterson PN
JAMA Netw Open; 2021 Jan; 4(1):e2035470. PubMed ID: 33496796
[TBL] [Abstract][Full Text] [Related]
33. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.
Ghali JK; Boehmer J; Feldman AM; Saxon LA; Demarco T; Carson P; Yong P; Galle EG; Leigh J; Ecklund FL; Bristow MR
J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827
[TBL] [Abstract][Full Text] [Related]
34. Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy. The Resynchronization for the HemodYnamic Treatment for Heart Failure Management II implantable cardioverter defibrillator (RHYTHM II ICD) study.
Boriani G; Müller CP; Seidl KH; Grove R; Vogt J; Danschel W; Schuchert A; Djiane P; Biffi M; Becker T; Bailleul C; Trappe HJ;
Am Heart J; 2006 May; 151(5):1050-8. PubMed ID: 16644335
[TBL] [Abstract][Full Text] [Related]
35. Cardiac Resynchronization in Women: A Substudy of the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial.
de Waard D; Manlucu J; Gillis AM; Sapp J; Bernick J; Doucette S; Tang A; Wells G; Parkash R
JACC Clin Electrophysiol; 2019 Sep; 5(9):1036-1044. PubMed ID: 31537332
[TBL] [Abstract][Full Text] [Related]
36. The efficacy and safety of cardiac resynchronization therapy combined with implantable cardioverter defibrillator for heart failure: a meta-analysis of 5674 patients.
Chen S; Ling Z; Kiuchi MG; Yin Y; Krucoff MW
Europace; 2013 Jul; 15(7):992-1001. PubMed ID: 23419662
[TBL] [Abstract][Full Text] [Related]
37. Survival with cardiac-resynchronization therapy in mild heart failure.
Goldenberg I; Kutyifa V; Klein HU; Cannom DS; Brown MW; Dan A; Daubert JP; Estes NA; Foster E; Greenberg H; Kautzner J; Klempfner R; Kuniss M; Merkely B; Pfeffer MA; Quesada A; Viskin S; McNitt S; Polonsky B; Ghanem A; Solomon SD; Wilber D; Zareba W; Moss AJ
N Engl J Med; 2014 May; 370(18):1694-701. PubMed ID: 24678999
[TBL] [Abstract][Full Text] [Related]
38. Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy.
Barra S; Looi KL; Gajendragadkar PR; Khan FZ; Virdee M; Agarwal S
Europace; 2016 Aug; 18(8):1187-93. PubMed ID: 26566940
[TBL] [Abstract][Full Text] [Related]
39. Impact of a Novel Adaptive Optimization Algorithm on 30-Day Readmissions: Evidence From the Adaptive CRT Trial.
Starling RC; Krum H; Bril S; Tsintzos SI; Rogers T; Hudnall JH; Martin DO
JACC Heart Fail; 2015 Jul; 3(7):565-572. PubMed ID: 26071616
[TBL] [Abstract][Full Text] [Related]
40. Cardiac resynchronization therapy reduces T-wave alternans in patients with heart failure.
Hua W; Chen K; Zhou X; Dai Y; Chen R; Wang J; Ding L; Liu Z; Feng T; Yu J; Cheng J; Liu C; Zhang S
Europace; 2015 Feb; 17(2):281-8. PubMed ID: 25398405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
